Deep Learning TME Analysis Improves Prognostic Discrimination in Stage III Colon Cancer | CancerNetwork

Quantifying tumor microenvironment (TME) features via a deep learning algorithm (QuantCRC) significantly enhanced prognostic discrimination when combined with postoperative circulating tumor DNA (ctDNA) status in patients with stage III colon cancer.¹ Findings from a retrospective analysis of the phase 3 NCCTG N0147 trial (NCT00079274) presented at the 2026 American Society of Oncology (ASCO) Annual Meeting suggest that integrating digital pathology-derived TME metrics with minimal residual disease (MRD) status provides a more comprehensive assessment of recurrence risk than clinical factors alone.

Key Prognostic and Histopathologic Data

The deep learning analysis revealed distinct TME profiles associated with MRD status. Patients who were ctDNA-positive exhibited a TME characterized by features including a higher proportion of stromal content, high-grade histology, and immature stroma within the tumor bed. Furthermore, ctDNA positivity was linked to increased tumor budding, poorly differentiated clusters, and the mature stroma within the stromal area.

In contrast, patients who were ctDNA-negative demonstrated TMEs associated with robust immune infiltration. These cases showed significantly higher tumor cellularity, greater tumor-infiltrating lymphocyte (TIL) density, and increased inflammatory stromal features.

Multivariable analysis demonstrated that QuantCRC feature-outcome associations were both ctDNA-independent and ctDNA-dependent. Specific features consistently associated with adverse clinical outcomes across both cohorts included mature stromal features, tumor budding/poorly differentiated clusters, and higher mucin content.

Notably, inflammatory stromal features were associated with improved outcomes regardless of ctDNA status. However, higher TIL density was specifically associated with more favorable outcomes in the ctDNA-negative subgroup, suggesting that the prognostic relevance of certain immune features may depend on the absence of detectable MRD.

Impact on Prognostic Discrimination

The integration of QuantCRC features provided incremental prognostic value beyond standard clinical variables and MRD status. In nested Cox models, adding postoperative ctDNA status to clinical features increased the Harrell’s C-index by 0.062 for disease-free survival (DFS) and 0.044 for overall survival (OS).

The addition of QuantCRC features to a model already containing clinical and MRD data resulted in a further statistical gain, adding 0.018 to the C-index for DFS and 0.022 for OS. Likelihood ratio tests for these additions were highly significant, with P-values ranging from approximately 10^–17 to 10^–13. These data indicate that artificial intelligence (AI)-driven histopathologic quantification captures prognostic information that is not fully accounted for by either traditional clinical staging or molecular MRD detection.

“ctDNA positivity was associated with a more aggressive and stromal-rich TME, whereas ctDNA negativity is associated with more immune-infiltrated tumor,” said presenting study author Frank A. Sinicrope, MD, gastroenterologist at the Mayo Clinic, Rochester, and coauthors.¹ “QuantCRC feature-outcome associations demonstrated both ctDNA-independent and ctDNA-dependent prognostic patterns across DFS, OS, and treatment-related factor analyses, suggesting that the prognostic relevance of QuantCRC features may depend on postoperative ctDNA status.”

Trial Design and Patient Population

The study utilized data from the NCCTG N0147 (Alliance) trial, which evaluated folinic acidc, fluorouracil, and oxaliplatin (FOLFOX)-based adjuvant chemotherapy in patients with resected stage III colon adenocarcinoma. Researchers applied QuantCRC, an AI-based deep learning histopathologic algorithm, to digitized hematoxylin and eosin (H&E)-stained whole-slide images; 15 quantitative histopathologic features were extracted.

Out of the original trial cohort, 1817 patients met the requirements for data quality control. Investigators made associations between the histopathologic features, ctDNA status, and clinical outcomes such as OS and DFS.

The primary objective of the analysis was to quantify TME features and evaluate their association with postoperative ctDNA status. The ctDNA status was determined previously revealed using the Guardant Reveal assay.²

“The combination of ctDNA and QuantCRC features improved prognostic discrimination that further refined risk stratification in stage III colon cancer,” concluded the study authors.

Reference

1. Sinicrope FA, Shi Q, Segovia DI, et al. A deep learning approach to quantify tumor microenvironment features associated with postoperative ctDNA status and outcomes in a phase III FOLFOX-based adjuvant colon cancer trial (N0147; Alliance). J Clin Oncol. 2026;44(suppl 16):3525. doi:10.1200/JCO.2026.44.16_suppl.3525

3″],”creditCertificate”:[0,”13.75″],”customFields”:[1,[[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”franchise”],”value”:[0,”PER”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-05-30″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”>3″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”13.75″]}],[0,{“label”:[0,”release-date”],”value”:[0,”2026-04-09″]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Genitourinary Cancer”]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”project-number”],”value”:[0,”IPC-26-0000000″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Maha Hussain, MD, FACP, FASCO; Daniel P. Petrylak, MD”],”url”:[0,”https://www.gotoper.com/courses/19th-annual-new-york-gu-cancers-congress-c68z?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”ManagedHealthcareExec”]]],”TI_id”:[0,”2952f4f1-e891-4e24-a8d2-a3b12c9d8694″],”title”:[0,”Go to PER in Chicago”],”releaseDate”:[0,”2025-04-08T04:00:00″],”courseEndDate”:[0,”2026-05-31T03:59:59″],”description”:[0,”May 29-31, 2026″],”slug”:[0,”annual-oncology-meeting”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/9ukuq48sg5q4-TICatalog800x4502x.png”]}],”contentTypeLabel”:[0,”In-Person + Virtual Event”],”activity-type”:[0,”In Person”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”>3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”venue”],”value”:[0,”Sheraton Grand Chicago Riverwalk”]}],[0,{“label”:[0,”location”],”value”:[0,”301 E North Water St, Chicago IL 60611″]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, New Drugs, Lung Cancer, Nursing Oncology, Pathology”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”>3″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”In Person”]}]]],”dataType”:[0,”PER”],”summary”:[0,”May 29-31, 2026″],”url”:[0,”https://www.gotoper.com/courses/annual-oncology-meeting?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”011cc759-f4c1-44d3-aaae-557410f45cd6″],”title”:[0,”Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | Tennessee Oncology Practice Society”],”releaseDate”:[0,”2026-04-30T13:17:20″],”courseEndDate”:[0,”2026-06-04T03:59:59″],”description”:[0,”Seth A. Wander, MD, PhD; Kamel Abou Hussein, MD”],”slug”:[0,”community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-tennessee-oncology-practice-society”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/dsh5hhl1gmja-d69edf32-474a-49bd-baa3-4aeb3f3e3a47.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.25″],”customFields”:[1,[[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.25″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-06-03″]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2026-04-30″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”project-number”],”value”:[0,”L00-00-0045552″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”franchise”],”value”:[0,”PER”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Seth A. Wander, MD, PhD; Kamel Abou Hussein, MD”],”url”:[0,”https://www.gotoper.com/courses/community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-tennessee-oncology-practice-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”5f624ff0-1ba1-4b21-992a-f3ffd43db239″],”title”:[0,”Iowa Oncology Society”],”releaseDate”:[0,”2023-12-09T05:00:00″],”courseEndDate”:[0,”2026-06-10T03:59:59″],”description”:[0,”2 Sessions are Available!”],”slug”:[0,”iowa-oncology-society”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/3m9sxjra92ui-IOWATICatalog750x361.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”Virtual Event”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”activity-type”],”value”:[0,”Virtual Event”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing, Nursing Oncology, Pharmacy, Gastrointestinal Cancer”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}]]],”dataType”:[0,”PER”],”summary”:[0,”2 Sessions are Available!”],”url”:[0,”https://www.gotoper.com/courses/iowa-oncology-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”8b9c9184-3f2d-4cf6-94e3-ce0c861439d5″],”title”:[0,”Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | Nevada Oncology Society”],”releaseDate”:[0,”2026-05-14T04:00:00″],”courseEndDate”:[0,”2026-06-18T03:59:59″],”description”:[0,”Seth A. Wander, MD, PhD; Ruta D. Rao, MD”],”slug”:[0,”community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-nevada-oncology-society”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/4ahckai0jnzc-d69edf32-474a-49bd-baa3-4aeb3f3e3a471111.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.25″],”customFields”:[1,[[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.25″]}],[0,{“label”:[0,”release-date”],”value”:[0,”2026-05-14″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”franchise”],”value”:[0,”PER”]}],[0,{“label”:[0,”project-number”],”value”:[0,”L00-00-0045552″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-06-17″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Seth A. Wander, MD, PhD; Ruta D. Rao, MD”],”url”:[0,”https://www.gotoper.com/courses/community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-nevada-oncology-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”69f59c39-967a-471e-b28c-284621da3e6d”],”title”:[0,”Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | The Arizona Clinical Oncology Society”],”releaseDate”:[0,”2026-05-14T04:00:00″],”courseEndDate”:[0,”2026-06-18T03:59:59″],”description”:[0,”Marla D. Lipsyc-Sharf, MD; Richard Zelkowitz, MD”],”slug”:[0,”community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-the-arizona-clinical-oncology-society”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/4ahckai0jnzc-d69edf32-474a-49bd-baa3-4aeb3f3e3a471111.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.25″],”customFields”:[1,[[0,{“label”:[0,”franchise”],”value”:[0,”PER”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology”]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2026-05-14″]}],[0,{“label”:[0,”project-number”],”value”:[0,”L00-00-0045552″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-06-17″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician”]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.25″]}]]],”dataType”:[0,”PER”],”summary”:[0,”Marla D. Lipsyc-Sharf, MD; Richard Zelkowitz, MD”],”url”:[0,”https://www.gotoper.com/courses/community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-the-arizona-clinical-oncology-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”f54ac855-5c47-4d4f-9940-14ba4eb2eac7″],”title”:[0,”Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | Missouri Oncology Society”],”releaseDate”:[0,”2026-05-14T04:00:00″],”courseEndDate”:[0,”2026-06-21T03:59:59″],”description”:[0,”Seth A. Wander, MD, PhD; Kate Baxstrom, MD”],”slug”:[0,”community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-missouri-oncology-society”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/fns3jqypax3w-d69edf32-474a-49bd-baa3-4aeb3f3e3a4711111.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.25″],”customFields”:[1,[[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.25″]}],[0,{“label”:[0,”release-date”],”value”:[0,”2026-05-14″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-06-20″]}],[0,{“label”:[0,”franchise”],”value”:[0,”PER”]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”project-number”],”value”:[0,”L00-00-0045552″]}]]],”dataType”:[0,”PER”],”summary”:[0,”Seth A. Wander, MD, PhD; Kate Baxstrom, MD”],”url”:[0,”https://www.gotoper.com/courses/community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-missouri-oncology-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”CGTLive”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”a1860f27-5d0f-4b7c-9f0a-5307c94ef3f5″],”title”:[0,”Wyoming State Oncology Society”],”releaseDate”:[0,”2024-01-13T05:00:00″],”courseEndDate”:[0,”2026-06-24T03:59:59″],”description”:[0,”2 Sessions are Available!”],”slug”:[0,”wyoming-state-oncology-society”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/gde3uj77eyjo-WyomingTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”In Person”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Hematologic Cancer, New Drugs, Gastrointestinal Cancer, General Oncology, Medical Oncology, Nursing Oncology”]}]]],”dataType”:[0,”PER”],”summary”:[0,”2 Sessions are Available!”],”url”:[0,”https://www.gotoper.com/courses/wyoming-state-oncology-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”319bd006-2d49-4bc0-8388-fada39250db1″],”title”:[0,”Kansas Society of Clinical Oncology”],”releaseDate”:[0,”2023-12-10T05:00:00″],”courseEndDate”:[0,”2026-06-26T03:59:59″],”description”:[0,”1 Session is Available!”],”slug”:[0,”kansas-society-of-clinical-oncology”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/bdh4hmfds430-KansasTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”Virtual Event”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”activity-type”],”value”:[0,”Virtual Event”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing, Nursing Oncology, Pharmacy”]}]]],”dataType”:[0,”PER”],”summary”:[0,”1 Session is Available!”],”url”:[0,”https://www.gotoper.com/courses/kansas-society-of-clinical-oncology?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”CGTLive”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”a1dd06d3-f705-49ff-8723-0fd6f9a7da8c”],”title”:[0,”North Carolina Oncology Association”],”releaseDate”:[0,”2023-12-25T05:00:00″],”courseEndDate”:[0,”2026-06-27T03:59:59″],”description”:[0,”2 Sessions are Available!”],”slug”:[0,”north-carolina-oncology-association”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/brirlh4bybxb-NCTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”Virtual Event”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”activity-type”],”value”:[0,”Virtual Event”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Hematologic Cancer, New Drugs, Gastrointestinal Cancer, General Oncology, Medical Oncology, Nursing Oncology”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}]]],”dataType”:[0,”PER”],”summary”:[0,”2 Sessions are Available!”],”url”:[0,”https://www.gotoper.com/courses/north-carolina-oncology-association?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”23f1518f-f7f7-4ced-a61e-b7fe36d26404″],”title”:[0,”A Case-Guided Discussion on Managing Immune Thrombocytopenic Purpura (ITP)”],”releaseDate”:[0,”2025-06-30T04:00:00″],”courseEndDate”:[0,”2026-07-01T03:59:59″],”description”:[0,”Cindy Neunert, MD, MSCS; Hanny Al-Samkari, MD; Joseph Shatzel, MD, MCR”],”slug”:[0,”a-case-guided-discussion-on-managing-immune-thrombocytopenic-purpura-itp-o00j”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/xvyhdq8x6nyz-ASCO25_ITP_TICatalog750x3611.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.5″],”customFields”:[1,[[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PEM-25-SSM2676″]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-06-30″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.5″]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-06-30″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Cindy Neunert, MD, MSCS; Hanny Al-Samkari, MD; Joseph Shatzel, MD, MCR”],”url”:[0,”https://www.gotoper.com/courses/a-case-guided-discussion-on-managing-immune-thrombocytopenic-purpura-itp-o00j?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”8d670878-6224-4927-8dd9-9d94f80cff7b”],”title”:[0,”Community Oncology Connections™: Beyond Primary End Points – Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | Wisconsin Association of Hematology and Oncology”],”releaseDate”:[0,”2026-05-28T20:06:49″],”courseEndDate”:[0,”2026-07-02T03:59:59″],”description”:[0,”Seth A. Wander, MD, PhD; Yang Liu, MD”],”slug”:[0,”community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-wisconsin-association-of-hematology-and-oncology-twpw”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/h1l8jjhkgl8b-d69edf32-474a-49bd-baa3-4aeb3f3e3a47111111.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.25″],”customFields”:[1,[[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.25″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”franchise”],”value”:[0,”PER”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-01″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2026-05-28″]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology”]}],[0,{“label”:[0,”proposal-id”],”value”:[0,”L00-00-0045552″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Seth A. Wander, MD, PhD; Yang Liu, MD”],”url”:[0,”https://www.gotoper.com/courses/community-oncology-connections-beyond-primary-end-points-digging-into-randomized-and-real-world-data-to-guide-challenging-treatment-decisions-in-hrher2-metastatic-breast-cancer-wisconsin-association-of-hematology-and-oncology-twpw?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”2b39b01c-f046-4ded-b772-c266b414c4f6″],”title”:[0,”Louisiana Oncology Society”],”releaseDate”:[0,”2023-12-11T05:00:00″],”courseEndDate”:[0,”2026-07-09T03:59:59″],”description”:[0,”2 Sessions are Available!”],”slug”:[0,”louisiana-oncology-society”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/kphe9onn9don-LouisianaTICatalog750x361copy2.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”In Person”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing, Nursing Oncology, Pharmacy, Gastrointestinal Cancer”]}]]],”dataType”:[0,”PER”],”summary”:[0,”2 Sessions are Available!”],”url”:[0,”https://www.gotoper.com/courses/louisiana-oncology-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”ac6dd006-fb30-4779-8c78-b83386d9467a”],”title”:[0,”Missouri Oncology Society”],”releaseDate”:[0,”2023-12-17T05:00:00″],”courseEndDate”:[0,”2026-07-10T03:59:59″],”description”:[0,”2 Sessions are Available!”],”slug”:[0,”missouri-oncology-society”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/98eut5eutqgq-MissoriTICatalog750x3611.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”Virtual Event”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”activity-type”],”value”:[0,”Virtual Event”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology, Nursing, Pharmacy, Gastrointestinal Cancer”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}]]],”dataType”:[0,”PER”],”summary”:[0,”2 Sessions are Available!”],”url”:[0,”https://www.gotoper.com/courses/missouri-oncology-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”c95bf857-1599-4e70-afd3-c03d85de8519″],”title”:[0,”New Mexico Society of Clinical Oncology”],”releaseDate”:[0,”2023-12-23T05:00:00″],”courseEndDate”:[0,”2026-07-11T03:59:59″],”description”:[0,”2 Sessions are Available!”],”slug”:[0,”new-mexico-society-of-clinical-oncology”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/e89u73qlbg09-NewMexicoTICatalog750x3612x.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”Virtual Event”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”activity-type”],”value”:[0,”Virtual Event”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology, Nursing, Pharmacy, Gastrointestinal Cancer”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}]]],”dataType”:[0,”PER”],”summary”:[0,”2 Sessions are Available!”],”url”:[0,”https://www.gotoper.com/courses/new-mexico-society-of-clinical-oncology?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”CGTLive”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”46ee5a1c-7b29-4b8f-97eb-9506be5b8d13″],”title”:[0,”10th Annual Live Medical Crossfire®: Hematologic Malignancies”],”releaseDate”:[0,”2025-04-22T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”July 11-12, 2026″],”slug”:[0,”live-medical-crossfire-hematologic-malignancies”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/ihbslbsjh79s-MXH26_TICatalog750x3612x.png”]}],”contentTypeLabel”:[0,”In-Person + Virtual Event”],”activity-type”:[0,”In Person”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”keywords”],”value”:[0,”MXH, 10th annual mxh”]}],[0,{“label”:[0,”cvent-event-code”],”value”:[0,”24e25ae6-6a9b-4f2a-9585-5558d60b8920″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”In Person”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Hematologic Cancer, General Oncology”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}]]],”dataType”:[0,”PER”],”summary”:[0,”July 11-12, 2026″],”url”:[0,”https://www.gotoper.com/courses/live-medical-crossfire-hematologic-malignancies?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”CGTLive”]]],”TI_id”:[0,”677d1678-49b5-4310-b754-7867e658cf78″],”title”:[0,”Cases & Conversations™: Transforming AML Care—Precision Strategies, Evolving Therapies, and Clinical Insights”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”Gail J. Roboz, MD; Hagop Kantarjian, MD; Catherine Lai, MD, MPH; Amer Zeidan, MBBS, MHS”],”slug”:[0,”cases-conversations-transforming-aml-careprecision-strategies-evolving-therapies-and-clinical-insights-91pp”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/yghd89xssfic-ASCO25_ADCMBCTICatalog750x3611.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”2.0″],”customFields”:[1,[[0,{“label”:[0,”credit-certificate”],”value”:[0,”2.0″]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2674″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Hematologic Cancer, Hematology, New Drugs”]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}]]],”dataType”:[0,”PER”],”summary”:[0,”Gail J. Roboz, MD; Hagop Kantarjian, MD; Catherine Lai, MD, MPH; Amer Zeidan, MBBS, MHS”],”url”:[0,”https://www.gotoper.com/courses/cases-conversations-transforming-aml-careprecision-strategies-evolving-therapies-and-clinical-insights-91pp?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”ManagedHealthcareExec”]]],”TI_id”:[0,”78c2b8d6-a630-43bc-bd8b-ac4cc97eee8a”],”title”:[0,”Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”Balazs Halmos, MD, MS; Enriqueta Felip, MD, PhD; Julia Rotow, MD”],”slug”:[0,”tumor-board-expert-insights-on-managing-classical-mutations-exon-20-insertions-and-atypical-mutations-in-metastatic-nsclc”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/59jw3aa4jil5-ASCO25_MFPVTICatalog750x3611.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”2.0″],”customFields”:[1,[[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2690″]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”2.0″]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Lung Cancer, Medical Oncology, New Drugs”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Balazs Halmos, MD, MS; Enriqueta Felip, MD, PhD; Julia Rotow, MD”],”url”:[0,”https://www.gotoper.com/courses/tumor-board-expert-insights-on-managing-classical-mutations-exon-20-insertions-and-atypical-mutations-in-metastatic-nsclc?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”66c5e0bc-bcfd-4fd8-8f96-0e915ccfe1f9″],”title”:[0,”Medical Crossfire®: Precision Medicine in Glioma Treatment — Integration of Molecular Profiling to Inform Targeted Therapies”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Stephen J. Bagley, MD, MSCE; Angela Waanders, MD, MPH, MS”],”slug”:[0,”medical-crossfire-precision-medicine-in-glioma-treatment-integration-of-molecular-profiling-to-inform-targeted-therapies-57yy”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/kr7oe4jyzc1p-ASCO25_Glioma_TICatalog750x361.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”2.0″],”customFields”:[1,[[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2666″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”2.0″]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Pediatric Oncology”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Stephen J. Bagley, MD, MSCE; Angela Waanders, MD, MPH, MS”],”url”:[0,”https://www.gotoper.com/courses/medical-crossfire-precision-medicine-in-glioma-treatment-integration-of-molecular-profiling-to-inform-targeted-therapies-57yy?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”ManagedHealthcareExec”],[0,”DiagnosticImaging”]]],”TI_id”:[0,”6a5f7696-ccbd-478e-84c7-ba034b28fbc1″],”title”:[0,”PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”Jonathan W. Goldman, MD; Percy Lee, MD, FASTRO; Erminia Massarelli, MD, PhD, MS; Misty D. Shields, MD, PhD”],”slug”:[0,”per-tumor-board-applying-recent-advances-to-transform-the-treatment-paradigm-in-sclcexpert-perspectives-on-new-approvals-and-emerging-strategies-rus2″],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/maa4feem2maa-ASCO25_SCLCTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”2.0″],”customFields”:[1,[[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Lung Cancer, Medical Oncology, New Drugs, Radiation Oncology, Supportive Care, Surgical Oncology”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”2.0″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2672″]}]]],”dataType”:[0,”PER”],”summary”:[0,”Jonathan W. Goldman, MD; Percy Lee, MD, FASTRO; Erminia Massarelli, MD, PhD, MS; Misty D. Shields, MD, PhD”],”url”:[0,”https://www.gotoper.com/courses/per-tumor-board-applying-recent-advances-to-transform-the-treatment-paradigm-in-sclcexpert-perspectives-on-new-approvals-and-emerging-strategies-rus2?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”CGTLive”]]],”TI_id”:[0,”1b2013cc-5db7-403e-a4a4-0bc378dda99c”],”title”:[0,”Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”Rami Komrokji, MD; Gabriela Hobbs, MD; John Mascarenhas, MD; Naveen Pemmaraju, MD”],”slug”:[0,”medical-crossfire-improving-patient-outcomes-in-myeloproliferative-neoplasms-with-novel-therapeutic-approaches-1″],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/2bg381rlbfzn-ASCO25_MFPVTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.5″],”customFields”:[1,[[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2681″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Hematologic Cancer, Hematology, New Drugs, Nursing, Nursing Oncology”]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.5″]}]]],”dataType”:[0,”PER”],”summary”:[0,”Rami Komrokji, MD; Gabriela Hobbs, MD; John Mascarenhas, MD; Naveen Pemmaraju, MD”],”url”:[0,”https://www.gotoper.com/courses/medical-crossfire-improving-patient-outcomes-in-myeloproliferative-neoplasms-with-novel-therapeutic-approaches-1?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”5ff9b352-0d9d-409d-8044-74482a025198″],”title”:[0,”Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”William J. Gradishar, MD, FASCO, FACP; Laura Huppert, MD; Yuan Yuan, MD, PhD”],”slug”:[0,”medical-crossfire-integrating-next-generation-endocrine-targeting-therapies-to-improve-outcomes-for-patients-with-hrher2-breast-cancer-td3z”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/c87kvobslhs1-ASCO25__NGSERDSTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.5″],”customFields”:[1,[[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.5″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2664″]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology”]}]]],”dataType”:[0,”PER”],”summary”:[0,”William J. Gradishar, MD, FASCO, FACP; Laura Huppert, MD; Yuan Yuan, MD, PhD”],”url”:[0,”https://www.gotoper.com/courses/medical-crossfire-integrating-next-generation-endocrine-targeting-therapies-to-improve-outcomes-for-patients-with-hrher2-breast-cancer-td3z?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”CGTLive”]]],”TI_id”:[0,”fed2d87a-ff71-4aa5-9659-5587e6a39abb”],”title”:[0,”Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD”],”slug”:[0,”cases-and-conversations-sorting-through-the-expanding-treatment-options-for-patients-with-relapsedrefractory-multiple-myeloma-wink”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/7wvhdmjbpzq3-ASCORRMMTICatalog750x3611.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.5″],”customFields”:[1,[[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2691″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.5″]}],[0,{“label”:[0,”specialty”],”value”:[0,”Blood Disorders, General Oncology, Hematologic Cancer, Hematology, Medical Oncology, New Drugs, Nursing Oncology”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}]]],”dataType”:[0,”PER”],”summary”:[0,”C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD”],”url”:[0,”https://www.gotoper.com/courses/cases-and-conversations-sorting-through-the-expanding-treatment-options-for-patients-with-relapsedrefractory-multiple-myeloma-wink?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”CGTLive”]]],”TI_id”:[0,”5cfba4cd-5597-4ee0-8ff2-96a3f74c2458″],”title”:[0,”Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD”],”slug”:[0,”medical-crossfire-harnessing-the-power-of-modern-therapies-in-newly-diagnosed-multiple-myeloma-1″],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/g9kw82ybkuhu-NDMMTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”2.0″],”customFields”:[1,[[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Hematologic Cancer, Medical Oncology, Nursing Oncology”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”2.0″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2651″]}]]],”dataType”:[0,”PER”],”summary”:[0,”C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD”],”url”:[0,”https://www.gotoper.com/courses/medical-crossfire-harnessing-the-power-of-modern-therapies-in-newly-diagnosed-multiple-myeloma-1?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”c1aba31a-1161-41b3-b2fd-7eb1b7b6a435″],”title”:[0,”GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”John H. Strickler, MD; Stacey A. Cohen, MD; Aparna Parikh, MD; Kanwal P.S. Raghav, MBBS, MD”],”slug”:[0,”gi-tumor-board-applying-recent-advances-in-biomarker-testing-and-treatment-in-metastatic-colorectal-cancer-wy9o”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/jza3dsdt148o-ASCO25_mCRC_TICatalog750x361.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”2.0″],”customFields”:[1,[[0,{“label”:[0,”specialty”],”value”:[0,”Gastrointestinal Cancer, General Oncology, New Drugs, Nursing Oncology, Pathology”]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”2.0″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2604″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}]]],”dataType”:[0,”PER”],”summary”:[0,”John H. Strickler, MD; Stacey A. Cohen, MD; Aparna Parikh, MD; Kanwal P.S. Raghav, MBBS, MD”],”url”:[0,”https://www.gotoper.com/courses/gi-tumor-board-applying-recent-advances-in-biomarker-testing-and-treatment-in-metastatic-colorectal-cancer-wy9o?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”ManagedHealthcareExec”]]],”TI_id”:[0,”864492f1-7c69-4864-bf6e-9fac031339d6″],”title”:[0,”Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”Rebecca Heist, MD, MPH; Alex A. Adjei, MD, PhD, FACP; Sandip Patel, MD, FASCO; Jeremy Segal, MD, PhD”],”slug”:[0,”medical-crossfire-expert-perspectives-on-targeting-c-met-overexpression-and-genomic-alterations-in-nsclc-unveiling-the-complexities-of-dysregulation”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/0gkab0ujdbjx-ASCO25_cMETTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.5″],”customFields”:[1,[[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2696″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Lung Cancer, Medical Oncology, New Drugs”]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.5″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Rebecca Heist, MD, MPH; Alex A. Adjei, MD, PhD, FACP; Sandip Patel, MD, FASCO; Jeremy Segal, MD, PhD”],”url”:[0,”https://www.gotoper.com/courses/medical-crossfire-expert-perspectives-on-targeting-c-met-overexpression-and-genomic-alterations-in-nsclc-unveiling-the-complexities-of-dysregulation?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”3784793c-db2c-43ac-8d52-403bb5ed92d6″],”title”:[0,”Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing”],”releaseDate”:[0,”2025-07-11T04:00:00″],”courseEndDate”:[0,”2026-07-12T03:59:59″],”description”:[0,”Eileen M. O’Reilly, MD; E. Gabriela Chiorean, MD, FASCO; Michael J. Pishvaian, MD, PhD; Brian Wolpin, MD, MPH”],”slug”:[0,”evolving-treatment-strategies-in-pancreatic-cancer-current-standards-emerging-targets-and-the-role-of-molecular-testing-6sf3″],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/f6pr04p7pj23-ASCOPDACTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.5″],”customFields”:[1,[[0,{“label”:[0,”credit-type”],”value”:[0,”CME”]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-11″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.5″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”specialty”],”value”:[0,”Gastrointestinal Cancer, General Oncology, Medical Oncology, New Drugs, Pathology”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-11″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician”]}],[0,{“label”:[0,”keywords”],”value”:[0,”ASCO”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2677″]}]]],”dataType”:[0,”PER”],”summary”:[0,”Eileen M. O’Reilly, MD; E. Gabriela Chiorean, MD, FASCO; Michael J. Pishvaian, MD, PhD; Brian Wolpin, MD, MPH”],”url”:[0,”https://www.gotoper.com/courses/evolving-treatment-strategies-in-pancreatic-cancer-current-standards-emerging-targets-and-the-role-of-molecular-testing-6sf3?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”6c94ed1e-f2e1-42aa-b51e-be92e5b8803c”],”title”:[0,”Wisconsin Association of Hematology and Oncology”],”releaseDate”:[0,”2024-01-09T05:00:00″],”courseEndDate”:[0,”2026-07-22T03:59:59″],”description”:[0,”1 Session is Available!”],”slug”:[0,”wisconsin-association-of-hematology-and-oncology”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/wgudqze7hnwa-WisconsinTICatalog750x3612x.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”Virtual Event”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”activity-type”],”value”:[0,”Virtual Event”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology, Nursing, Pharmacy”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}]]],”dataType”:[0,”PER”],”summary”:[0,”1 Session is Available!”],”url”:[0,”https://www.gotoper.com/courses/wisconsin-association-of-hematology-and-oncology?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”09737caa-8958-4ca0-ab77-e897c14dd56c”],”title”:[0,”Indiana Oncology Society”],”releaseDate”:[0,”2023-12-08T05:00:00″],”courseEndDate”:[0,”2026-07-23T03:59:59″],”description”:[0,”2 Sessions are Available!”],”slug”:[0,”indiana-oncology-society”],”thumbnail”:[0,{“url”:[0,”https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/rw1nm3tz01z9-IndianaTICatalog750x3612x.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”Virtual Event”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”activity-type”],”value”:[0,”Virtual Event”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing, Nursing Oncology, Pharmacy, Gastrointestinal Cancer”]}]]],”dataType”:[0,”PER”],”summary”:[0,”2 Sessions are Available!”],”url”:[0,”https://www.gotoper.com/courses/indiana-oncology-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”CGTLive”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”9d0518d7-0322-4918-aafe-c48878ae85c9″],”title”:[0,”Kentucky Society of Clinical Oncology”],”releaseDate”:[0,”2023-12-10T05:00:00″],”courseEndDate”:[0,”2026-07-25T03:59:59″],”description”:[0,”2 Sessions are Available!”],”slug”:[0,”kentucky-society-of-clinical-oncology”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/hxnf9ink93mn-COC_Regions_WebsiteBanners_KentuckyTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”In Person”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Hematologic Cancer, New Drugs, Gastrointestinal Cancer, General Oncology, Medical Oncology, Nursing Oncology”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}]]],”dataType”:[0,”PER”],”summary”:[0,”2 Sessions are Available!”],”url”:[0,”https://www.gotoper.com/courses/kentucky-society-of-clinical-oncology?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”b8cf77c1-5a44-4f47-85ef-b353d5a79b71″],”title”:[0,”Rhode Island Oncology Society”],”releaseDate”:[0,”2023-12-27T05:00:00″],”courseEndDate”:[0,”2026-07-25T03:59:59″],”description”:[0,”3 Sessions are Available!”],”slug”:[0,”rhode-island-oncology-society”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/37lc20qwxv0o-COC_Regions_WebsiteBanners_RhodeIslandTICatalog750x361.png”]}],”contentTypeLabel”:[0,”Virtual Event”],”activity-type”:[0,”In Person”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,null],”customFields”:[1,[[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing, Nursing Oncology, Pharmacy, Gastrointestinal Cancer”]}]]],”dataType”:[0,”PER”],”summary”:[0,”3 Sessions are Available!”],”url”:[0,”https://www.gotoper.com/courses/rhode-island-oncology-society?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”ff0e0ef4-85d5-4e52-9bbb-73f403aa4864″],”title”:[0,”Breast Cancer Tumor Board: Targeting TROP2 – Innovations in Triple-Negative Breast Cancer Treatment”],”releaseDate”:[0,”2025-07-31T15:39:46″],”courseEndDate”:[0,”2026-08-01T03:59:59″],”description”:[0,”Joyce O’Shaughnessy, MD; Matthew P. Goetz, MD; Hope S. Rugo, MD, FASCO”],”slug”:[0,”breast-cancer-tumor-board-targeting-trop2-innovations-in-triple-negative-breast-cancer-treatment”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/ta57zyep0zig-TICatalog750x3612x.png”]}],”contentTypeLabel”:[0,”Video”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.0″],”customFields”:[1,[[0,{“label”:[0,”release-date”],”value”:[0,”2025-07-31″]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-07-31″]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology”]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-SSM2660″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.0″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Joyce O’Shaughnessy, MD; Matthew P. Goetz, MD; Hope S. Rugo, MD, FASCO”],”url”:[0,”https://www.gotoper.com/courses/breast-cancer-tumor-board-targeting-trop2-innovations-in-triple-negative-breast-cancer-treatment?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”TargetedOncology”],[0,”Onclive”],[0,”CenterForBiosimilars”]]],”TI_id”:[0,”b2038dc8-0755-404e-a74a-33704e14b37a”],”title”:[0,”Expert Guidance on Frequently Asked Questions Regarding the Use of ADCs in TNBC”],”releaseDate”:[0,”2025-08-15T14:26:23″],”courseEndDate”:[0,”2026-08-16T03:59:59″],”description”:[0,”Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc”],”slug”:[0,”expert-guidance-on-frequently-asked-questions-regarding-the-use-of-adcs-in-tnbc”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/rtliwczmdaar-RC_TNBC_Burst6_WebBanners_TICatalog750x361.png”]}],”contentTypeLabel”:[0,”Multimedia”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME”],”creditAmount”:[0,”<1"],"creditCertificate":[0,"0.25"],"customFields":[1,[[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-15"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"specialty"],"value":[0,"Breast Cancer, General Oncology, Medical Oncology, New Drugs"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2720"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.25"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-15"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}]]],"dataType":[0,"PER"],"summary":[0,"Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc"],"url":[0,"https://www.gotoper.com/courses/expert-guidance-on-frequently-asked-questions-regarding-the-use-of-adcs-in-tnbc?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"TargetedOncology"],[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"67c19a6a-e53a-43ef-9409-b2dbfeeedfc2"],"title":[0,"Establishing the Rationale for ADC and ICI Combinations in TNBC"],"releaseDate":[0,"2025-08-15T13:25:44"],"courseEndDate":[0,"2026-08-16T03:59:59"],"description":[0,"Virginia Kaklamani, MD, DSc; Tiffany A. Traina, MD, FASCO"],"slug":[0,"establishing-the-rationale-for-adc-and-ici-combinations-in-tnbc"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/srhsxhdjznwm-RC_TNBC_Burst3_WebBanners_TICatalog750x3611.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.25"],"customFields":[1,[[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2720"]}],[0,{"label":[0,"specialty"],"value":[0,"Breast Cancer, General Oncology, Medical Oncology, New Drugs"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-15"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-15"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.25"]}]]],"dataType":[0,"PER"],"summary":[0,"Virginia Kaklamani, MD, DSc; Tiffany A. Traina, MD, FASCO"],"url":[0,"https://www.gotoper.com/courses/establishing-the-rationale-for-adc-and-ici-combinations-in-tnbc?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"TargetedOncology"],[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"f3a0b988-e7a2-4068-aaaf-d3fae49f055c"],"title":[0,"Dissecting Clinical Trial and Real-World Data for ADCs in TNBC"],"releaseDate":[0,"2025-08-15T04:00:00"],"courseEndDate":[0,"2026-08-16T03:59:59"],"description":[0,"Filipa Lynce, MD; Rita Nanda, MD"],"slug":[0,"dissecting-clinical-trial-and-real-world-data-for-adcs-in-tnbc"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/22g2bmh99gzw-RC_TNBC_Burst2_WebBanners_TICatalog750x361.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.25"],"customFields":[1,[[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-15"]}],[0,{"label":[0,"specialty"],"value":[0,"Breast Cancer, General Oncology, Medical Oncology, New Drugs"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-15"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2720"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.25"]}]]],"dataType":[0,"PER"],"summary":[0,"Filipa Lynce, MD; Rita Nanda, MD"],"url":[0,"https://www.gotoper.com/courses/dissecting-clinical-trial-and-real-world-data-for-adcs-in-tnbc?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"TargetedOncology"],[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"86239036-3887-4894-ae4d-4dd01a48816e"],"title":[0,"Breaking Down the Rationale for Targeting TROP2 in TNBC"],"releaseDate":[0,"2025-08-15T04:00:00"],"courseEndDate":[0,"2026-08-16T03:59:59"],"description":[0,"Filipa Lynce, MD; Rita Nanda, MD"],"slug":[0,"breaking-down-the-rationale-for-targeting-trop2-in-tnbc"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/efw9u1dll09b-RC_TNBC_Burst1_WebBanners_TICatalog750x361.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.25"],"customFields":[1,[[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-15"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-15"]}],[0,{"label":[0,"specialty"],"value":[0,"Breast Cancer, General Oncology, Medical Oncology, New Drugs"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2720"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.25"]}]]],"dataType":[0,"PER"],"summary":[0,"Filipa Lynce, MD; Rita Nanda, MD"],"url":[0,"https://www.gotoper.com/courses/breaking-down-the-rationale-for-targeting-trop2-in-tnbc?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"TargetedOncology"],[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"44605cde-f929-4d62-972c-2f520029f4af"],"title":[0,"Evaluating the Latest Data and Ongoing Trials for Novel ADC Approaches in TNBC"],"releaseDate":[0,"2025-08-15T13:44:42"],"courseEndDate":[0,"2026-08-16T03:59:59"],"description":[0,"Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD"],"slug":[0,"evaluating-the-latest-data-and-ongoing-trials-for-novel-adc-approaches-in-tnbc"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/ye6e6rjigmbr-RC_TNBC_Burst4_WebBanners_TICatalog750x361.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.25"],"customFields":[1,[[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2720"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.25"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-15"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-15"]}],[0,{"label":[0,"specialty"],"value":[0,"Breast Cancer, General Oncology, Medical Oncology, New Drugs"]}]]],"dataType":[0,"PER"],"summary":[0,"Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD"],"url":[0,"https://www.gotoper.com/courses/evaluating-the-latest-data-and-ongoing-trials-for-novel-adc-approaches-in-tnbc?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"ManagedHealthcareExec"]]],"TI_id":[0,"702dc812-5da0-42e5-b05d-8999763e2ff5"],"title":[0,"Breaking Down the Latest Clinical Data for First-line Maintenance and R/R SCLC"],"releaseDate":[0,"2025-08-20T04:00:00"],"courseEndDate":[0,"2026-08-21T03:59:59"],"description":[0,"Rahul Gosain, MD, MBA; Rohit Gosain, MD; Hossein Borghaei, DO, MS"],"slug":[0,"breaking-down-the-latest-clinical-data-for-first-line-maintenance-and-rr-sclc"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/mq6339uv0f9n-RC_SCLC_Module2_TICatalog750x3612x1.png"]}],"contentTypeLabel":[0,"Audio"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.25"],"customFields":[1,[[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2738"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.25"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Lung Cancer, Medical Oncology"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-20"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-20"]}]]],"dataType":[0,"PER"],"summary":[0,"Rahul Gosain, MD, MBA; Rohit Gosain, MD; Hossein Borghaei, DO, MS"],"url":[0,"https://www.gotoper.com/courses/breaking-down-the-latest-clinical-data-for-first-line-maintenance-and-rr-sclc?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"e200fca1-341f-4ec1-a6a9-eff26723ba01"],"title":[0,"Optimizing Treatment for Biliary Tract Cancers"],"releaseDate":[0,"2025-08-26T04:00:00"],"courseEndDate":[0,"2026-08-27T03:59:59"],"description":[0,"Ghassan Abou-Alfa, MD, MBA; Laura Williams Goff, MD, MSCI, MMHC, FASCO; Arndt Vogel, MD, PhD"],"slug":[0,"optimizing-treatment-for-biliary-tract-cancers"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/9dvo7geewegq-TICatalog750x3612x56.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.5"],"customFields":[1,[[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-26"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.5"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"specialty"],"value":[0,"Gastrointestinal Cancer, General Oncology, Medical Oncology, New Drugs"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-VTH2730"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-26"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}]]],"dataType":[0,"PER"],"summary":[0,"Ghassan Abou-Alfa, MD, MBA; Laura Williams Goff, MD, MSCI, MMHC, FASCO; Arndt Vogel, MD, PhD"],"url":[0,"https://www.gotoper.com/courses/optimizing-treatment-for-biliary-tract-cancers?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"927a8f97-d2f0-4415-b8b0-676973487dd8"],"title":[0,"Broadening the Frontline—Studies Informing the Use of Immunotherapy in Hepatocellular Carcinoma"],"releaseDate":[0,"2025-08-26T04:00:00"],"courseEndDate":[0,"2026-08-27T03:59:59"],"description":[0,"Ghassan Abou-Alfa, MD, MBA; Laura Williams Goff, MD, MSCI, MMHC, FASCO; Arndt Vogel, MD, PhD"],"slug":[0,"broadening-the-frontlinestudies-informing-the-use-of-immunotherapy-in-hepatocellular-carcinoma"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/qjgujs9rx10s-TICatalog750x3612x55.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.5"],"customFields":[1,[[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-26"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-VTH2730"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.5"]}],[0,{"label":[0,"specialty"],"value":[0,"Gastrointestinal Cancer, General Oncology, Medical Oncology, New Drugs"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-26"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}]]],"dataType":[0,"PER"],"summary":[0,"Ghassan Abou-Alfa, MD, MBA; Laura Williams Goff, MD, MSCI, MMHC, FASCO; Arndt Vogel, MD, PhD"],"url":[0,"https://www.gotoper.com/courses/broadening-the-frontlinestudies-informing-the-use-of-immunotherapy-in-hepatocellular-carcinoma?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"3455ad36-9f64-4662-a353-70f357081dbd"],"title":[0,"Cross-Disease Integration of Immunotherapy Innovations"],"releaseDate":[0,"2025-08-26T04:00:00"],"courseEndDate":[0,"2026-08-27T03:59:59"],"description":[0,"Ghassan Abou-Alfa, MD, MBA; Laura Williams Goff, MD, MSCI, MMHC, FASCO; Arndt Vogel, MD, PhD"],"slug":[0,"cross-disease-integration-of-immunotherapy-innovations"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/ou5z3m4q8077-TICatalog750x3612x57.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.5"],"customFields":[1,[[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-26"]}],[0,{"label":[0,"specialty"],"value":[0,"Gastrointestinal Cancer, General Oncology, Medical Oncology, New Drugs"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.5"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-26"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-VTH2730"]}]]],"dataType":[0,"PER"],"summary":[0,"Ghassan Abou-Alfa, MD, MBA; Laura Williams Goff, MD, MSCI, MMHC, FASCO; Arndt Vogel, MD, PhD"],"url":[0,"https://www.gotoper.com/courses/cross-disease-integration-of-immunotherapy-innovations?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"ManagedHealthcareExec"]]],"TI_id":[0,"55289fbb-9d81-4e90-bf30-f0b6ec7f2f9c"],"title":[0,"Practical Considerations and Future Directions for New Treatment Strategies in SCLC"],"releaseDate":[0,"2025-08-29T04:00:00"],"courseEndDate":[0,"2026-08-30T03:59:59"],"description":[0,"Rahul Gosain, MD, MBA; Rohit Gosain, MD; Misty D. Shields, MD, PhD"],"slug":[0,"practical-considerations-and-future-directions-for-new-treatment-strategies-in-sclc"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/mhgctxab1vja-RC_SCLC_Module3_TICatalog750x3612x1.png"]}],"contentTypeLabel":[0,"Audio"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.25"],"customFields":[1,[[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-29"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.25"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Lung Cancer, Medical Oncology"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-29"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2738"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}]]],"dataType":[0,"PER"],"summary":[0,"Rahul Gosain, MD, MBA; Rohit Gosain, MD; Misty D. Shields, MD, PhD"],"url":[0,"https://www.gotoper.com/courses/practical-considerations-and-future-directions-for-new-treatment-strategies-in-sclc?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"TargetedOncology"],[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"f9b2463e-2e63-4b81-b431-72b4d66df2d8"],"title":[0,"PER Resource Center: Integrating Novel Approaches in TNBC – New Avenues for TROP2-Targeting ADCs and Beyond – Nursing"],"releaseDate":[0,"2025-08-29T13:22:51"],"courseEndDate":[0,"2026-08-30T03:59:59"],"description":[0,"Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc; Filipa Lynce, MD; Rita Nanda, MD; Tiffany A. Traina, MD, FASCO"],"slug":[0,"per-resource-center-integrating-novel-approaches-in-tnbc-new-avenues-for-trop2-targeting-adcs-and-beyond-nursing"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/kkh7eak70u1c-RC_TNBC_Landing_WebBanners_TICatalogNursing750x361copy.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"NCPD"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"1.5"],"customFields":[1,[[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2720"]}],[0,{"label":[0,"credit-type"],"value":[0,"NCPD"]}],[0,{"label":[0,"specialty"],"value":[0,"Breast Cancer, General Oncology, Medical Oncology, New Drugs"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"1.5"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-29"]}],[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"profession"],"value":[0,"Nurse"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-29"]}]]],"dataType":[0,"PER"],"summary":[0,"Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc; Filipa Lynce, MD; Rita Nanda, MD; Tiffany A. Traina, MD, FASCO"],"url":[0,"https://www.gotoper.com/courses/per-resource-center-integrating-novel-approaches-in-tnbc-new-avenues-for-trop2-targeting-adcs-and-beyond-nursing?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"TargetedOncology"],[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"a138fd19-95c9-4026-8579-c93e4a9360d9"],"title":[0,"Expert Roundtable and Panel Discussions: Current and Future Landscape of TNBC"],"releaseDate":[0,"2025-08-29T04:00:00"],"courseEndDate":[0,"2026-08-30T03:59:59"],"description":[0,"Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Tiffany A. Traina, MD, FASCO"],"slug":[0,"expert-roundtable-and-panel-discussions-current-and-future-landscape-of-tnbc"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/pbgh750ngnfz-RC_TNBC_Burst5_WebBanners_TICatalog750x361.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.25"],"customFields":[1,[[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2720"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-29"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"specialty"],"value":[0,"Breast Cancer, General Oncology, Medical Oncology, New Drugs"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-29"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.25"]}]]],"dataType":[0,"PER"],"summary":[0,"Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Tiffany A. Traina, MD, FASCO"],"url":[0,"https://www.gotoper.com/courses/expert-roundtable-and-panel-discussions-current-and-future-landscape-of-tnbc?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"TargetedOncology"],[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"4252204b-1242-4231-b33f-bc60ab5dd0c9"],"title":[0,"Show Me the Data®: New and Emerging Roles for Oral SERD Therapy in the Treatment of ER+/HER2– Breast Cancer"],"releaseDate":[0,"2025-08-29T04:00:00"],"courseEndDate":[0,"2026-08-30T03:59:59"],"description":[0,"Ana C. Garrido-Castro, MD; Pedram Razavi, MD, PhD"],"slug":[0,"show-me-the-data-new-and-emerging-roles-for-oral-serd-therapy-in-the-treatment-of-erher2-breast-cancer-r3ot"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/jb3zlwrlde7m-FLASCO_SERDSTICatalog750x361.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME, NCPD"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"1.0"],"customFields":[1,[[0,{"label":[0,"project-number"],"value":[0,"PER-25-SSM2695"]}],[0,{"label":[0,"profession"],"value":[0,"Physician, Nurse"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"1.0"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-08-29"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-08-29"]}],[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"specialty"],"value":[0,"Breast Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME, NCPD"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}]]],"dataType":[0,"PER"],"summary":[0,"Ana C. Garrido-Castro, MD; Pedram Razavi, MD, PhD"],"url":[0,"https://www.gotoper.com/courses/show-me-the-data-new-and-emerging-roles-for-oral-serd-therapy-in-the-treatment-of-erher2-breast-cancer-r3ot?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"ManagedHealthcareExec"]]],"TI_id":[0,"a7768cab-cba4-41c1-a2e4-f9f6a296c048"],"title":[0,"Navigating Treatment Gaps in SCLC: Relapse, Resistance, and Need for New Options"],"releaseDate":[0,"2025-09-04T14:09:01"],"courseEndDate":[0,"2026-09-05T03:59:59"],"description":[0,"Rahul Gosain, MD, MBA; Rohit Gosain, MD; Giannis Mountzios ΜD, PhD"],"slug":[0,"navigating-treatment-gaps-in-sclc-relapse-resistance-and-need-for-new-options"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/wr2x0ig1mtsg-RC_SCLC_Module1_TICatalog750x3612x1.png"]}],"contentTypeLabel":[0,"Audio"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.25"],"customFields":[1,[[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.25"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Lung Cancer, Medical Oncology"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2738"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-09-04"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-04"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}]]],"dataType":[0,"PER"],"summary":[0,"Rahul Gosain, MD, MBA; Rohit Gosain, MD; Giannis Mountzios ΜD, PhD"],"url":[0,"https://www.gotoper.com/courses/navigating-treatment-gaps-in-sclc-relapse-resistance-and-need-for-new-options?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"UrologyTimes"]]],"TI_id":[0,"eda3680f-485b-4c22-a98d-962a4ddfc027"],"title":[0,"Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment"],"releaseDate":[0,"2024-08-30T04:00:00"],"courseEndDate":[0,"2026-09-07T03:59:59"],"description":[0,"Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD"],"slug":[0,"medical-crossfire-in-adjunctive-testing-charting-a-new-course-in-prostate-cancer-risk-assessment"],"thumbnail":[0,{"url":[0,"https://d36ai2hkxl16us.cloudfront.net/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/vlgczrbfyprr-TICatalog750x3612x213.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME, NCPD"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"1.5"],"customFields":[1,[[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Urology"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"project-number"],"value":[0,"PEM-24-MXF2525"]}],[0,{"label":[0,"profession"],"value":[0,"Physician, Nurse"]}],[0,{"label":[0,"release-date"],"value":[0,"2024-08-30"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"1.5"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-06"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME, NCPD"]}]]],"dataType":[0,"PER"],"summary":[0,"Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD"],"url":[0,"https://www.gotoper.com/courses/medical-crossfire-in-adjunctive-testing-charting-a-new-course-in-prostate-cancer-risk-assessment?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"CGTLive"],[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"14dbf783-95c7-434a-b21a-798d23452ab3"],"title":[0,"Imaging Matters: Decoding PSMA PET for Better Decision-Making"],"releaseDate":[0,"2025-09-12T04:00:00"],"courseEndDate":[0,"2026-09-13T03:59:59"],"description":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO"],"slug":[0,"imaging-matters-decoding-psma-pet-for-better-decision-making"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/37hp13pwkkxa-RC_PSMA_Module1_TICatalog750x3612x.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.5"],"customFields":[1,[[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-12"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.5"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2725"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-09-12"]}],[0,{"label":[0,"specialty"],"value":[0,"Hematologic Cancer, General Oncology, Patient Safety"]}]]],"dataType":[0,"PER"],"summary":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO"],"url":[0,"https://www.gotoper.com/courses/imaging-matters-decoding-psma-pet-for-better-decision-making?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"DiagnosticImaging"],[0,"UrologyTimes"]]],"TI_id":[0,"4fa4cd37-81dd-4b0a-a86a-8aa33fbbd7f2"],"title":[0,"Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care"],"releaseDate":[0,"2025-09-12T04:00:00"],"courseEndDate":[0,"2026-09-13T03:59:59"],"description":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO"],"slug":[0,"working-together-overcoming-barriers-to-optimize-outcomes-in-patients-treated-with-radioligand-therapy-through-multidisciplinary-care"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/yaumpi7ng0p7-RC_PSMA_Module4_TICatalog750x3612x.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.5"],"customFields":[1,[[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.5"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2725"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Genitourinary Cancer, Medical Oncology, New Drugs, Nursing Oncology, Radiation Oncology, Radiology, Urology"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-12"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-09-12"]}]]],"dataType":[0,"PER"],"summary":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO"],"url":[0,"https://www.gotoper.com/courses/working-together-overcoming-barriers-to-optimize-outcomes-in-patients-treated-with-radioligand-therapy-through-multidisciplinary-care?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"DiagnosticImaging"],[0,"UrologyTimes"]]],"TI_id":[0,"810b8771-7b23-4114-a276-ec73b89f4fe5"],"title":[0,"Radioligand Therapy 101: The Science Behind the Strategy"],"releaseDate":[0,"2025-09-12T04:00:00"],"courseEndDate":[0,"2026-09-13T03:59:59"],"description":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO"],"slug":[0,"radioligand-therapy-101-the-science-behind-the-strategy"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/qj156a8rp9lc-RC_PSMA_Module2_TICatalog750x3612x.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.5"],"customFields":[1,[[0,{"label":[0,"release-date"],"value":[0,"2025-09-12"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Genitourinary Cancer, Medical Oncology, New Drugs, Nursing Oncology, Radiation Oncology, Radiology, Urology"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2725"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-12"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.5"]}]]],"dataType":[0,"PER"],"summary":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO"],"url":[0,"https://www.gotoper.com/courses/radioligand-therapy-101-the-science-behind-the-strategy?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"DiagnosticImaging"],[0,"UrologyTimes"]]],"TI_id":[0,"4b806c19-6f73-4b35-8c7b-8bcde2dd1a15"],"title":[0,"Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified"],"releaseDate":[0,"2025-09-12T04:00:00"],"courseEndDate":[0,"2026-09-13T03:59:59"],"description":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO"],"slug":[0,"ready-for-radioligand-therapy-patient-selection-and-sequencing-simplified"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/g9qdckruqk67-RC_PSMA_Module3_TICatalog750x3612x1.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"<1"],"creditCertificate":[0,"0.5"],"customFields":[1,[[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2725"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Genitourinary Cancer, Medical Oncology, New Drugs, Nursing Oncology, Radiation Oncology, Radiology, Urology"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"profession"],"value":[0,"Physician"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"0.5"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-12"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-09-12"]}],[0,{"label":[0,"credit-amount"],"value":[0,"<1"]}]]],"dataType":[0,"PER"],"summary":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO"],"url":[0,"https://www.gotoper.com/courses/ready-for-radioligand-therapy-patient-selection-and-sequencing-simplified?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"DiagnosticImaging"],[0,"UrologyTimes"]]],"TI_id":[0,"16f978ee-81e4-4f58-ad1f-dac27030013f"],"title":[0,"BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer"],"releaseDate":[0,"2025-09-12T04:00:00"],"courseEndDate":[0,"2026-09-13T03:59:59"],"description":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO"],"slug":[0,"burst-cme-resource-center-integrating-novel-psma-directed-radioligand-approaches-for-diagnosis-and-management-of-prostate-cancer"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/cxoucbnblwrp-TICatalog750x3612x1.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"NCPD"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"2.0"],"customFields":[1,[[0,{"label":[0,"release-date"],"value":[0,"2025-09-12"]}],[0,{"label":[0,"profession"],"value":[0,"Nurse"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"2.0"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-12"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-OAD2725"]}],[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"credit-type"],"value":[0,"NCPD"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Genitourinary Cancer, Medical Oncology, New Drugs, Nursing Oncology, Radiation Oncology, Radiology, Urology"]}]]],"dataType":[0,"PER"],"summary":[0,"Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO"],"url":[0,"https://www.gotoper.com/courses/burst-cme-resource-center-integrating-novel-psma-directed-radioligand-approaches-for-diagnosis-and-management-of-prostate-cancer?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"ManagedHealthcareExec"]]],"TI_id":[0,"9a8e4c7d-aa6c-4106-9e49-7719422ff45f"],"title":[0,"A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and ADCs"],"releaseDate":[0,"2025-09-30T04:00:00"],"courseEndDate":[0,"2026-10-01T03:59:59"],"description":[0,"Sandip Patel, MD, FASCO; Myung-Ju Ahn, MD; Giannis Mountzios, MD, MSc, PhD; Zofia Piotrowska, MD, MHS"],"slug":[0,"a-new-era-of-targeted-therapy-for-advanced-nsclc-exploring-future-directions-for-bispecific-antibodies-and-adcs-full"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/4del2bqu1148-WCLC25_NSCLC_TICatalog750x3612x.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME, NCPD"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"1.0"],"customFields":[1,[[0,{"label":[0,"credit-certificate"],"value":[0,"1.0"]}],[0,{"label":[0,"project-number"],"value":[0,"PEG-25-SSM2718"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-30"]}],[0,{"label":[0,"profession"],"value":[0,"Physician, Nurse"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME, NCPD"]}],[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-09-30"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Lung Cancer, Medical Oncology, New Drugs, Nursing Oncology"]}]]],"dataType":[0,"PER"],"summary":[0,"Sandip Patel, MD, FASCO; Myung-Ju Ahn, MD; Giannis Mountzios, MD, MSc, PhD; Zofia Piotrowska, MD, MHS"],"url":[0,"https://www.gotoper.com/courses/a-new-era-of-targeted-therapy-for-advanced-nsclc-exploring-future-directions-for-bispecific-antibodies-and-adcs-full?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"ManagedHealthcareExec"]]],"TI_id":[0,"67da1eb4-dd59-445b-aa99-438b90bf70a9"],"title":[0," Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum"],"releaseDate":[0,"2025-09-30T04:00:00"],"courseEndDate":[0,"2026-10-01T03:59:59"],"description":[0,"Tina Cascone, MD, PhD; Christina Baik, MD, MPH; David Planchard, MD, PhD"],"slug":[0,"tumor-board-advances-in-managing-egfr-mutant-nsclc-applying-evidence-across-the-disease-continuum-full"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/3kx376feg3uv-WCLC25_EGFR_WebBanners_WCLC25_EGFR_TIDetail800x450.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME, NCPD"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"1.0"],"customFields":[1,[[0,{"label":[0,"release-date"],"value":[0,"2025-09-30"]}],[0,{"label":[0,"profession"],"value":[0,"Physician, Nurse"]}],[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-30"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"1.0"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Lung Cancer, Medical Oncology, New Drugs, Pathology"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME, NCPD"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-SSM2753"]}]]],"dataType":[0,"PER"],"summary":[0,"Tina Cascone, MD, PhD; Christina Baik, MD, MPH; David Planchard, MD, PhD"],"url":[0,"https://www.gotoper.com/courses/tumor-board-advances-in-managing-egfr-mutant-nsclc-applying-evidence-across-the-disease-continuum-full?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"]]],"TI_id":[0,"e2399e51-16d8-455f-b5b8-73dab6f548be"],"title":[0,"Community Practice Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy–Strategies for the Multidisciplinary Team"],"releaseDate":[0,"2025-09-30T04:00:00"],"courseEndDate":[0,"2026-10-01T03:59:59"],"description":[0,"Yana G. Najjar, MD; Sapna Patel, MD"],"slug":[0,"community-practice-connections-enhancing-melanoma-outcomes-with-intratumoral-oncolytic-immunotherapystrategies-for-the-multidisciplinary-team"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/cbetqd4bydyf-TICatalog750x3612x61.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME, NCPD"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"1.25"],"customFields":[1,[[0,{"label":[0,"release-date"],"value":[0,"2025-09-30"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-ASV2723"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"1.25"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-09-30"]}],[0,{"label":[0,"specialty"],"value":[0,"Dermatologic Cancer, General Oncology, Medical Oncology, New Drugs, Nursing Oncology, Radiology, Surgical Oncology"]}],[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME, NCPD"]}],[0,{"label":[0,"profession"],"value":[0,"Physician, Nurse"]}]]],"dataType":[0,"PER"],"summary":[0,"Yana G. Najjar, MD; Sapna Patel, MD"],"url":[0,"https://www.gotoper.com/courses/community-practice-connections-enhancing-melanoma-outcomes-with-intratumoral-oncolytic-immunotherapystrategies-for-the-multidisciplinary-team?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"OphthalmologyTimes"],[0,"OptometryTimes"],[0,"ModernRetina"]]],"TI_id":[0,"cccf9288-3d40-4075-b87e-47a36f27bdd4"],"title":[0,"Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO"],"releaseDate":[0,"2025-10-15T04:00:00"],"courseEndDate":[0,"2026-10-16T03:59:59"],"description":[0,"SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS"],"slug":[0,"navigating-advances-in-neovascular-retinal-disease-translating-evidence-to-practice-in-amd-dme-and-rvo-archive"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/sfk7t7uzkle9-EyeConISSRetinaTICatalog750x36111.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"1.0"],"customFields":[1,[[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Ophthalmology"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-10-15"]}],[0,{"label":[0,"project-number"],"value":[0,"PEM-25-SSM2707"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-10-15"]}],[0,{"label":[0,"profession"],"value":[0,"Optometrist, Physician"]}],[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"1.0"]}]]],"dataType":[0,"PER"],"summary":[0,"SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS"],"url":[0,"https://www.gotoper.com/courses/navigating-advances-in-neovascular-retinal-disease-translating-evidence-to-practice-in-amd-dme-and-rvo-archive?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"DiagnosticImaging"],[0,"UrologyTimes"]]],"TI_id":[0,"5c6caef6-c79a-4257-a77b-a5c96404d899"],"title":[0,"Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies"],"releaseDate":[0,"2025-10-23T04:00:00"],"courseEndDate":[0,"2026-10-24T03:59:59"],"description":[0,"Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP"],"slug":[0,"enhancing-prostate-cancer-outcomes-the-role-of-psma-and-targeted-treatment-strategies"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/ejrytw6kcfaa-ASTRO25_GUTumorBoard_TICatalog750x3612x.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME, NCPD"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"2.0"],"customFields":[1,[[0,{"label":[0,"expiration-date"],"value":[0,"2026-10-23"]}],[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Genitourinary Cancer, Medical Oncology, New Drugs, Nursing Oncology, Pharmacy, Radiation Oncology, Urology"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"2.0"]}],[0,{"label":[0,"profession"],"value":[0,"Physician, Nurse"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME, NCPD"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-SSM2732"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-10-23"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}]]],"dataType":[0,"PER"],"summary":[0,"Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP"],"url":[0,"https://www.gotoper.com/courses/enhancing-prostate-cancer-outcomes-the-role-of-psma-and-targeted-treatment-strategies?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"TargetedOncology"],[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"ManagedHealthcareExec"]]],"TI_id":[0,"e9b6938f-6237-45f1-ae23-a5f1e7660544"],"title":[0,"(CME Track) Antibody–Drug Conjugates in Oncology: The Essentials of AE Management for Better Patient Outcomes"],"releaseDate":[0,"2025-11-07T05:00:00"],"courseEndDate":[0,"2026-11-08T04:59:59"],"description":[0,"Michelle L. Taylor, ANP-BC; Emely Alfaro, DNP, RN, CNS, OCN; Paige Griffith, CRNP; Beth Sandy, MSN, CRNP, FAPO"],"slug":[0,"antibodydrug-conjugates-in-oncology-the-essentials-of-ae-management-for-better-patient-outcomes-85b4"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/55zgdkqpwrj2-ADCJADPROTICatalog750x3612x.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME, CPE"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"1.5"],"customFields":[1,[[0,{"label":[0,"uan-number"],"value":[0,"0661-0000-25-017-H01-P"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-11-07"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"1.5"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-SSM2764"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"profession"],"value":[0,"Physician, Pharmacist"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-11-07"]}],[0,{"label":[0,"specialty"],"value":[0,"Breast Cancer, Gastroenterology, General Oncology, Lung Cancer, Medical Oncology, New Drugs, Nursing, Nursing Oncology"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME, CPE"]}],[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}]]],"dataType":[0,"PER"],"summary":[0,"Michelle L. Taylor, ANP-BC; Emely Alfaro, DNP, RN, CNS, OCN; Paige Griffith, CRNP; Beth Sandy, MSN, CRNP, FAPO"],"url":[0,"https://www.gotoper.com/courses/antibodydrug-conjugates-in-oncology-the-essentials-of-ae-management-for-better-patient-outcomes-85b4?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"ManagedHealthcareExec"]]],"TI_id":[0,"3d89d8ab-7b2e-4b04-9345-ba164eb444a7"],"title":[0," Personalized Approaches in NSCLC: Early Detection, Molecular Testing, and Targeted Therapies"],"releaseDate":[0,"2025-11-25T05:00:00"],"courseEndDate":[0,"2026-11-26T04:59:59"],"description":[0,"Charu Aggarwal, MD, MPH, FASCO; Zofia Piotrowska, MD, MHS"],"slug":[0,"community-practice-connections-personalized-approaches-in-nsclc-early-detection-molecular-testing-and-targeted-therapies"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/dq3bn3d30ld9-COC25_NSCLC_CPCBanners_COC25_NSCLC_TICatalog750x3612.png"]}],"contentTypeLabel":[0,"Multimedia"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME, NCPD"],"creditAmount":[0,"1 to 3"],"creditCertificate":[0,"1.0"],"customFields":[1,[[0,{"label":[0,"credit-amount"],"value":[0,"1 to 3"]}],[0,{"label":[0,"expiration-date"],"value":[0,"2026-11-25"]}],[0,{"label":[0,"credit-certificate"],"value":[0,"1.0"]}],[0,{"label":[0,"release-date"],"value":[0,"2025-11-25"]}],[0,{"label":[0,"activity-type"],"value":[0,"Online Activity"]}],[0,{"label":[0,"credit-type"],"value":[0,"CME, NCPD"]}],[0,{"label":[0,"profession"],"value":[0,"Physician, Nurse"]}],[0,{"label":[0,"specialty"],"value":[0,"General Oncology, Lung Cancer, Medical Oncology, New Drugs, Nursing, Nursing Oncology"]}],[0,{"label":[0,"project-number"],"value":[0,"PER-25-ASC2710"]}]]],"dataType":[0,"PER"],"summary":[0,"Charu Aggarwal, MD, MPH, FASCO; Zofia Piotrowska, MD, MHS"],"url":[0,"https://www.gotoper.com/courses/community-practice-connections-personalized-approaches-in-nsclc-early-detection-molecular-testing-and-targeted-therapies?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck"],"_id":[0],"published":[0]}],[0,{"brandNames":[1,[[0,"TargetedOncology"],[0,"Onclive"],[0,"CenterForBiosimilars"],[0,"CGTLive"],[0,"ManagedHealthcareExec"],[0,"DiagnosticImaging"]]],"TI_id":[0,"4087d518-988c-40e4-9f7d-46aafd500cf7"],"title":[0,"9th Annual School of Nursing Oncology™"],"releaseDate":[0,"2025-11-25T05:00:00"],"courseEndDate":[0,"2026-11-26T04:59:59"],"description":[0,"Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO; Beth Sandy, MSN, CRNP, FAPO; Lindsay Adkins, MSN, FNP-BC, BMTCN; Jeneth Aquino, DNP, FNP-BC; Casey Gormley, MSN, FNP-C, AOCNP; Heather J. Jackson, PhD, FNP-BC; Kelsey Martin, AG-ACNP-BC, AOCNP; Nerina T. McDonald, PA-C; Lauren Verity Moore, DNP, MSN, AGACNP-BC; Faith A. Mutale, DNP, CRNP; Tiffany Richards, PhD, ANP-BC, AOCNP; Emily Skotte, DNP, MSN, ACNP-BC; Leslie Smith, DNP, RN, APRN-CNS, AOCNS, BMTCN; Saneese Stephen, PA-C, MPAS; Sara M. Tinsley-Vance, PhD, APRN, AOCN"],"slug":[0,"9th-annual-school-of-nursing-oncology-efgj"],"thumbnail":[0,{"url":[0,"https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/48695vqkp5cp-TICatalog750x3612x21.png"]}],"contentTypeLabel":[0,"Video"],"activity-type":[0,"Online Activity"],"creditType":[0,"CME, NCPD"],"creditAmount":[0,">3″],”creditCertificate”:[0,”7.25″],”customFields”:[1,[[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”specialty”],”value”:[0,”Breast Cancer, Gastrointestinal Cancer, General Oncology, Genitourinary Cancer, Gynecologic Cancer, Hematologic Cancer, Lung Cancer, New Drugs, Nursing Oncology, Radiation Oncology”]}],[0,{“label”:[0,”project-number”],”value”:[0,”SNO-25-0000000″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”7.25″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”>3″]}],[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-11-25″]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-11-25″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}]]],”dataType”:[0,”PER”],”summary”:[0,”Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO; Beth Sandy, MSN, CRNP, FAPO; Lindsay Adkins, MSN, FNP-BC, BMTCN; Jeneth Aquino, DNP, FNP-BC; Casey Gormley, MSN, FNP-C, AOCNP; Heather J. Jackson, PhD, FNP-BC; Kelsey Martin, AG-ACNP-BC, AOCNP; Nerina T. McDonald, PA-C; Lauren Verity Moore, DNP, MSN, AGACNP-BC; Faith A. Mutale, DNP, CRNP; Tiffany Richards, PhD, ANP-BC, AOCNP; Emily Skotte, DNP, MSN, ACNP-BC; Leslie Smith, DNP, RN, APRN-CNS, AOCNS, BMTCN; Saneese Stephen, PA-C, MPAS; Sara M. Tinsley-Vance, PhD, APRN, AOCN”],”url”:[0,”https://www.gotoper.com/courses/9th-annual-school-of-nursing-oncology-efgj?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”ManagedHealthcareExec”]]],”TI_id”:[0,”ace6371c-e378-4b73-864c-014eae9ca6f5″],”title”:[0,”Community Practice Connections™: Optimizing SCLC Treatment Strategies and Managing Adverse Events Across Disease Stages”],”releaseDate”:[0,”2025-11-25T05:00:00″],”courseEndDate”:[0,”2026-11-26T04:59:59″],”description”:[0,”Erminia Massarelli, MD, PhD, MS; Misty D. Shields, MD, PhD”],”slug”:[0,”community-practice-connections-optimizing-sclc-treatment-strategies-and-managing-adverse-events-across-disease-stages”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/b6bubvk7jt47-COC25_SCLCTreatment_CPCBanners_COC25_SCLCTreatment_TICatalog750x3611.png”]}],”contentTypeLabel”:[0,”Multimedia”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.0″],”customFields”:[1,[[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-11-25″]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.0″]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Lung Cancer, Medical Oncology, New Drugs”]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-11-25″]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-ASC2699″]}]]],”dataType”:[0,”PER”],”summary”:[0,”Erminia Massarelli, MD, PhD, MS; Misty D. Shields, MD, PhD”],”url”:[0,”https://www.gotoper.com/courses/community-practice-connections-optimizing-sclc-treatment-strategies-and-managing-adverse-events-across-disease-stages?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}],[0,{“brandNames”:[1,[[0,”Onclive”],[0,”CenterForBiosimilars”],[0,”ManagedHealthcareExec”]]],”TI_id”:[0,”a28c9a49-be8d-465e-afb8-a00d67b4a513″],”title”:[0,”Community Practice Connections™: DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer—From Innovation to Practice”],”releaseDate”:[0,”2025-11-26T05:00:00″],”courseEndDate”:[0,”2026-11-27T04:59:59″],”description”:[0,”Jacob Sands, MD; Anne Chiang, MD, PhD”],”slug”:[0,”community-practice-connections-dll3-targeting-bispecific-antibodies-for-small-cell-lung-cancerfrom-innovation-to-practice”],”thumbnail”:[0,{“url”:[0,”https://media.thoughtindustries.com/thoughtindustries/image/upload/v1/course-uploads/07c0d4e1-23aa-4e1a-8c5f-f2569da581c0/y0rr172cqu3z-CoC25_SCLC_CPCBanners_COC25_SCLC_TICatalog750x3611.png”]}],”contentTypeLabel”:[0,”Multimedia”],”activity-type”:[0,”Online Activity”],”creditType”:[0,”CME, NCPD”],”creditAmount”:[0,”1 to 3″],”creditCertificate”:[0,”1.0″],”customFields”:[1,[[0,{“label”:[0,”expiration-date”],”value”:[0,”2026-11-26″]}],[0,{“label”:[0,”project-number”],”value”:[0,”PER-25-ASC2763″]}],[0,{“label”:[0,”activity-type”],”value”:[0,”Online Activity”]}],[0,{“label”:[0,”profession”],”value”:[0,”Physician, Nurse”]}],[0,{“label”:[0,”credit-certificate”],”value”:[0,”1.0″]}],[0,{“label”:[0,”release-date”],”value”:[0,”2025-11-26″]}],[0,{“label”:[0,”credit-type”],”value”:[0,”CME, NCPD”]}],[0,{“label”:[0,”specialty”],”value”:[0,”General Oncology, Lung Cancer, Medical Oncology, New Drugs, Nursing Oncology, Nursing”]}],[0,{“label”:[0,”credit-amount”],”value”:[0,”1 to 3″]}]]],”dataType”:[0,”PER”],”summary”:[0,”Jacob Sands, MD; Anne Chiang, MD, PhD”],”url”:[0,”https://www.gotoper.com/courses/community-practice-connections-dll3-targeting-bispecific-antibodies-for-small-cell-lung-cancerfrom-innovation-to-practice?utm_source=cancernetwork&utm_medium=article&utm_campaign=cmeDeck”],”_id”:[0],”published”:[0]}]]],”contentTitle”:[0,”Latest CME”],”hidden”:[0,false]}” ssr client=”load” opts=”{“name”:”CmeSlider”,”value”:true}” await-children>